Prostate cancer specific integrin alphavbeta3 modulates bone metastatic growth and tissue remodeling.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMC 2753215)

Published in Oncogene on March 19, 2007

Authors

N P McCabe1, S De, A Vasanji, J Brainard, T V Byzova

Author Affiliations

1: Department of Molecular Cardiology, Joseph J Jacobs Center for Thrombosis and Vascular Biology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Articles citing this

Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16

An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med (2009) 2.10

Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev (2010) 1.92

Integrins in prostate cancer progression. Endocr Relat Cancer (2008) 1.56

Functional screen identifies kinases driving prostate cancer visceral and bone metastasis. Proc Natl Acad Sci U S A (2015) 1.51

Suppression of Spry4 enhances cancer stem cell properties of human MDA-MB-231 breast carcinoma cells. Cancer Cell Int (2016) 1.40

Steps in prostate cancer progression that lead to bone metastasis. Int J Cancer (2011) 1.34

αV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med (2011) 1.33

Therapeutic targeting of the prostate cancer microenvironment. Nat Rev Urol (2010) 1.22

Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. Am J Pathol (2011) 1.16

TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. Br J Cancer (2008) 1.13

Epithelial and mesenchymal phenotypic switchings modulate cell motility in metastasis. Front Biosci (Landmark Ed) (2011) 1.12

αVβ3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-κB activation. J Cell Physiol (2011) 1.09

Integrins and bone metastasis: integrating tumor cell and stromal cell interactions. Bone (2010) 1.09

Integrins and metastasis. Cell Adh Migr (2013) 1.08

Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer. Neoplasia (2011) 1.04

Identification of vitronectin as an extrinsic inducer of cancer stem cell differentiation and tumor formation. Stem Cells (2010) 1.03

Integrin αvβ6 promotes an osteolytic program in cancer cells by upregulating MMP2. Cancer Res (2014) 0.97

Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation. Br J Cancer (2012) 0.94

Synstatin: a selective inhibitor of the syndecan-1-coupled IGF1R-αvβ3 integrin complex in tumorigenesis and angiogenesis. FEBS J (2013) 0.91

The role of integrins in cancer and the development of anti-integrin therapeutic agents for cancer therapy. Perspect Medicin Chem (2008) 0.91

Phase II study of cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium. Invest New Drugs (2010) 0.91

Prostate cancer regulatory networks. J Cell Biochem (2009) 0.91

Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis (2007) 0.90

Nanoparticles for Improving Cancer Diagnosis. Mater Sci Eng R Rep (2013) 0.87

RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis. Cancers (Basel) (2012) 0.87

Identification of a small molecule class to enhance cell-cell adhesion and attenuate prostate tumor growth and metastasis. Mol Cancer Ther (2009) 0.86

Cathepsin H mediates the processing of talin and regulates migration of prostate cancer cells. J Biol Chem (2012) 0.86

Contribution of bone tissue modulus to breast cancer metastasis to bone. Cancer Microenviron (2011) 0.85

Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis. J Cell Physiol (2013) 0.85

Platelets govern pre-metastatic tumor communication to bone. Oncogene (2013) 0.85

Fibronectin matrix-mediated cohesion suppresses invasion of prostate cancer cells. BMC Cancer (2012) 0.84

Atomic basis for the species-specific inhibition of αV integrins by monoclonal antibody 17E6 is revealed by the crystal structure of αVβ3 ectodomain-17E6 Fab complex. J Biol Chem (2014) 0.84

Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models. Breast Cancer Res (2015) 0.83

Integrin trafficking and tumor progression. Int J Cell Biol (2011) 0.82

Activin B induces human endometrial cancer cell adhesion, migration and invasion by up-regulating integrin β3 via SMAD2/3 signaling. Oncotarget (2015) 0.81

Targeting bone physiology for the treatment of metastatic prostate cancer. Clin Adv Hematol Oncol (2013) 0.80

Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation. Mol Cancer (2014) 0.80

Anterior gradient protein-2 is a regulator of cellular adhesion in prostate cancer. PLoS One (2014) 0.79

The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells. Biochim Biophys Acta (2014) 0.79

Proteomic analysis of glioma chemoresistance. Curr Neuropharmacol (2012) 0.79

Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD. J Nucl Med (2016) 0.79

Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics (2016) 0.78

Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. J Hematol Oncol (2017) 0.77

Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines. BMC Cancer (2014) 0.77

Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models. Oncotarget (2016) 0.76

Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET. Oncotarget (2016) 0.76

Chemical and Biochemical Basis of Cell-Bone Matrix Interaction in Health and Disease. Curr Chem Biol (2009) 0.75

Theragnostic ultrasound using microbubbles in the treatment of prostate cancer. Ultrasonography (2016) 0.75

Exosome-mediated Transfer of αvβ3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype. Mol Cancer Res (2016) 0.75

Lipid Osteoclastokines Regulate Breast Cancer Bone Metastasis. Endocrinology (2016) 0.75

Isoprenylcysteine carboxylmethyltransferase function is essential for RAB4A-mediated integrin β3 recycling, cell migration and cancer metastasis. Oncogene (2017) 0.75

Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers (Basel) (2017) 0.75

Integrin αvβ3 Signaling in Tumor-Induced Bone Disease. Cancers (Basel) (2017) 0.75

Articles cited by this

Networks and crosstalk: integrin signalling spreads. Nat Cell Biol (2002) 4.66

Breaking the integrin hinge. A defined structural constraint regulates integrin signaling. J Biol Chem (1996) 4.45

Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07

Inside-out integrin signalling. Curr Opin Cell Biol (1992) 2.29

Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci U S A (2003) 2.21

Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia. Proc Natl Acad Sci U S A (1992) 1.95

Spread of prostatic cancer to bone. Urology (1983) 1.94

A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function. J Clin Invest (2001) 1.91

Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res (2006) 1.88

VEGF-integrin interplay controls tumor growth and vascularization. Proc Natl Acad Sci U S A (2005) 1.84

A push-pull mechanism for regulating integrin function. Proc Natl Acad Sci U S A (2005) 1.82

Prostate cancer bone metastases promote both osteolytic and osteoblastic activity. J Cell Biochem (2004) 1.77

Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J (2002) 1.64

Molecular pathway for cancer metastasis to bone. J Biol Chem (2003) 1.47

The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res (2005) 1.38

Activation of integrin alpha(V)beta(3) regulates cell adhesion and migration to bone sialoprotein. Exp Cell Res (2000) 1.30

Changes in extracellular matrix (ECM) and ECM-associated proteins in the metastatic progression of prostate cancer. Reprod Biol Endocrinol (2004) 1.29

Natural history and treatment of bone complications in prostate cancer. Eur Urol (2006) 1.26

Integrin beta3 overexpression suppresses tumor growth in a human model of gliomagenesis: implications for the role of beta3 overexpression in glioblastoma multiforme. Cancer Res (2004) 1.19

Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res (2005) 1.17

A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype. Blood (2001) 1.13

Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases. Clin Exp Metastasis (2003) 1.03

Articles by these authors

(truncated to the top 100)

Platelet GPIIb-IIIa blockers. Lancet (1999) 1.97

Effects of insertion conditions on tissue strain and vascular damage during neuroprosthetic device insertion. J Neural Eng (2006) 1.86

Regional variation in brain capillary density and vascular response to ischemia. Brain Res (2001) 1.82

Calcium metabolism in epilepsy. N Engl J Med (1969) 1.74

Limiting long-term illness and its associations with mortality and indicators of social deprivation. J Epidemiol Community Health (1995) 1.74

Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis (2011) 1.59

Removal of congo red using activated carbon and its regeneration. J Hazard Mater (2006) 1.54

Brush cytology vs. endoscopic biopsy for the surveillance of Barrett's esophagus. Endoscopy (2010) 1.42

Effects of Petroleum Ether Extract of Amorphophallus paeoniifolius Tuber on Central Nervous System in Mice. Indian J Pharm Sci (2009) 1.23

Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12

Optical coherence tomography as a diagnostic aid to visual inspection and colposcopy for preinvasive and invasive cancer of the uterine cervix. Int J Gynecol Cancer (2006) 1.11

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

PCR detection of Giardia lamblia in stool: targeting intergenic spacer region of multicopy rRNA gene. Mol Cell Probes (2000) 1.08

Transverse momentum distribution and nuclear modification factor of charged particles in p+Pb collisions at sqrt[s(NN)] = 5.02 TeV. Phys Rev Lett (2013) 1.08

The role of radiation therapy in the management of spinal cord compression due to extramedullary haematopoiesis in thalassaemia. J Neurol Neurosurg Psychiatry (1992) 1.07

Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett (2011) 1.05

Doxycycline in the treatment of cholera. Bull World Health Organ (1976) 1.04

Day-case myringoplasty: five years' experience. J Laryngol Otol (2003) 1.04

Immune response of children who develop persistent diarrhea following rotavirus infection. Clin Diagn Lab Immunol (1999) 0.99

Production of muons from heavy flavor decays at forward rapidity in pp and Pb-Pb collisions at sqrt[s(NN)]=2.76  TeV. Phys Rev Lett (2012) 0.98

Characteristics of responders to fluoxetine. Psychopharmacol Bull (1984) 0.97

Large-angle electron diffraction structure in laser-induced rescattering from rare gases. Phys Rev Lett (2008) 0.95

Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation. Br J Cancer (2012) 0.94

Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93

Mechanical properties of hydroxyapatite single crystals from nanoindentation data. J Mech Behav Biomed Mater (2010) 0.92

Differential mortality in Turkana agriculturalists and pastoralists. Am J Phys Anthropol (1986) 0.91

Primary radiation therapy in the management of glomus tumours. Indian J Cancer (1993) 0.91

Snoring surgery: a retrospective review. Laryngoscope (2005) 0.90

Cholera and blood-groups. Lancet (1977) 0.89

Complicated otitis media caused by Fusobacterium necrophorum. J Laryngol Otol (2004) 0.89

An isoflavone from Myristica malabarica. Phytochemistry (2000) 0.89

Control of electron localization in deuterium molecular ions using an attosecond pulse train and a many-cycle infrared pulse. Phys Rev Lett (2010) 0.86

Platelets govern pre-metastatic tumor communication to bone. Oncogene (2013) 0.85

Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III. J Thromb Haemost (2012) 0.85

Economic analysis of risk of gastrointestinal parasitic infection in cattle in North Eastern States of India. Trop Anim Health Prod (2010) 0.84

AlphaIIbbeta3 and its antagonism at the new millennium. Thromb Haemost (2001) 0.84

Ultrafast charge rearrangement and nuclear dynamics upon inner-shell multiple ionization of small polyatomic molecules. Phys Rev Lett (2013) 0.83

Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. Platelets (2002) 0.83

Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa. FEBS Lett (1996) 0.83

J/ψ elliptic flow in Pb-Pb collisions at √(s(NN))=2.76 TeV. Phys Rev Lett (2013) 0.82

Primary gastric lymphoma: a prospective analysis of 12 cases and review of the literature. J Surg Oncol (1990) 0.82

Conjugated linoleic acid producing potential of lactobacilli isolated from the rumen of cattle. J Ind Microbiol Biotechnol (2008) 0.82

Microhydration of Cs+ ion: a density functional theory study on Cs+-(H2O)n clusters (n=1-10). J Chem Phys (2007) 0.82

The added value of virtual reality technology and force feedback for surgical training simulators. Work (2012) 0.81

Congener-specific polychlorinated biphenyl-induced cell death in human kidney cells in vitro: potential role of caspase. Int J Toxicol (2006) 0.81

Estimation of tear glucose level and its role as a prompt indicator of blood sugar level. J Indian Med Assoc (2003) 0.81

Validation of cytokeratin 5/6 as an effective substitute for keratin 903 in the differentiation of benign from malignant glands in prostate needle biopsies. Histopathology (2002) 0.81

Adult embryonal rhabdomyosarcoma of the vagina complicating pregnancy: a case report and review of the literature. Asia Oceania J Obstet Gynaecol (1990) 0.81

Follow-up results of balloon angioplasty for native coarctation of aorta. Indian Heart J (1997) 0.81

Diphenoxylate hydrochloride (Lomotil) in the management of cholera. Indian J Med Res (1975) 0.81

Pseudorapidity density of charged particles in p+Pb collisions at √(s(NN))=5.02 TeV. Phys Rev Lett (2013) 0.81

Ion-energy dependence of asymmetric dissociation of D2 by a two-color laser field. Phys Rev Lett (2009) 0.80

Charge separation relative to the reaction plane in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2013) 0.80

Purification and characterization of enterocin FH 99 produced by a faecal isolate Enterococcus faecium FH 99. Indian J Microbiol (2010) 0.80

J/ψ polarization in pp collisions at √s=7 TeV. Phys Rev Lett (2012) 0.80

Adaptive strong-field control of chemical dynamics guided by three-dimensional momentum imaging. Nat Commun (2013) 0.80

Pion, kaon, and proton production in central Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 0.80

Sero-epidemiological evidence of Coxiella burnetii infection among selected human population in Calcutta. Indian J Med Res (1978) 0.80

Diazepam in tetanus. J Indian Med Assoc (1967) 0.80

A renal consult. J Pediatr Gastroenterol Nutr (2007) 0.80

Relative expression of the 14-3-3 gene in different morphotypes of cysts of Echinococcus granulosus isolated from the Indian buffalo. J Helminthol (2010) 0.80

Lysine(164)alpha of protein farnesyltransferase is important for both CaaX substrate binding and catalysis. Biochem J (2001) 0.80

Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods. Clin Chim Acta (2009) 0.79

Treatment of piriform fossa sinuses with monopolar diathermy. J Laryngol Otol (2007) 0.79

Endothelial heterogeneity and intimal blood-borne cells. Relation to human atherosclerosis. Ann N Y Acad Sci (1995) 0.79

Expression of bronchodilator response: comparison of four indices. Respir Med (2002) 0.79

Relative expression of antigen B coding gene of bubaline isolates of Echinococcus granulosus in fertile and sterile cysts. J Helminthol (2009) 0.78

Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines. Leukemia (2007) 0.78

Combined therapy in advanced head and neck cancers. J Laryngol Otol (1992) 0.78

Relationship of body compositional and nutritional parameters with blood pressure in adults. J Hum Nutr Diet (2013) 0.78

[Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex]. Biull Eksp Biol Med (1994) 0.78

Phosphatidylcholine activation of human heart (R)-3-hydroxybutyrate dehydrogenase mutants lacking active center sulfhydryls: site-directed mutagenesis of a new recombinant fusion protein. Biochemistry (2000) 0.78

Prevention of carcinogen-induced mouse skin papilloma by whole fruit aqueous extract of Momordica charantia. Eur J Cancer Prev (2000) 0.78

Effect of vitamin E supplementation on mRNA expression of superoxide dismutase and interleukin-2 in arsenic exposed goat leukocytes. Bull Environ Contam Toxicol (2012) 0.77

Embryonic genome activation events in buffalo (Bubalus bubalis) preimplantation embryos. Mol Reprod Dev (2012) 0.77

Metastatic malignant melanoma of the larynx. J Laryngol Otol (2001) 0.77

Characterization of oocyte-expressed GDF9 gene in buffalo and mapping of its TSS and putative regulatory elements. Zygote (2012) 0.77

Detection of viral DNA in endolymphatic sac tissue from Menière's disease patients. Am J Otol (1994) 0.77

Otitis media in children. Hosp Med (2005) 0.77

Anti-inflammatory and anti-nociceptive activity of the water decoction Desmodium gangeticum. J Ethnopharmacol (2004) 0.76

Effect of varying glucose concentrations during in vitro maturation and embryo culture on efficiency of in vitro embryo production in buffalo. Reprod Domest Anim (2011) 0.76

Minocycline, tetracycline and furazolidone in the treatment of cholera. Indian J Med Res (1977) 0.76

Corrosion resistance of polyurethane-coated nitinol cardiovascular stents. J Biomater Sci Polym Ed (2003) 0.76

Measurement of in-vivo force response of intra-abdominal soft tissues for surgical simulation. Stud Health Technol Inform (2002) 0.75

Adsorption of eosin dye on activated carbon and its surfactant based desorption. J Environ Manage (2005) 0.75

Intracranial metastasis in Ewing's sarcoma. Indian J Pediatr (1992) 0.75

Pamidronate and uveitis. Br J Rheumatol (1995) 0.75

J/ψ suppression at forward rapidity in Pb-Pb collisions at √s(NN) = 2.76 TeV. Phys Rev Lett (2012) 0.75

Charged-particle multiplicity density at midrapidity in central Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 0.75

Is general surgery going the way of dinosaur? J Indian Med Assoc (1996) 0.75

Ibuprofen (Brufen) in cholera and other diarrhoeas. Indian J Med Res (1974) 0.75

Stress inducible heat shock protein 70: a potent molecular and toxicological signature in arsenic exposed broiler chickens. Mol Biol Rep (2009) 0.75

Survey of gut colonisation with Stenotrophomonas maltophilia among neonates. J Hosp Infect (2009) 0.75

Precipitation of cetyl (hexadecyl) pyridineum chloride using mono and divalent oxyanions. J Hazard Mater (2008) 0.75

Comparison of performance characteristics of automated PCR systems with culture for detection of MTB complex from clinical samples in central India. Indian J Med Microbiol (2009) 0.75

Stressor-induced changes to the protoscoleces of Echinococcus granulosus of Indian buffalo origin. J Helminthol (2008) 0.75

Carbachol stimulates adenylate cyclase and phospholipase C and muscle contraction-relaxation in a reciprocal manner in dog iris sphincter smooth muscle. Eur J Pharmacol (1992) 0.75

Primary lymphoma of the brain--a report of 5 cases and review of the literature. Indian J Cancer (1991) 0.75

Group surgical practice: a new approach to rural surgery. J Indian Med Assoc (1992) 0.75

Role of radiotherapy in the management of primary carcinoma of the fallopian tube. Indian J Med Sci (1991) 0.75